Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded
- Contract number
- SPE2DB25FYQRV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,744
Award facts
- Contract value 100% obligated
- $14,744.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 14, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials, with a ceiling value of $14,744.31. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement through the DLA's Medical Supply Chain. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a comprehensive range of pharmaceutical products, including brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. The Ozempic order supports the Defense Health Agency and other government healthcare systems under the broader pharmaceutical supply framework managed by DLA Troop Support, which is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards in the coming years.
Quick answers
Who was awarded contract SPE2DB25FYQRV?
SPE2DB25FYQRV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 14, 2025.
How much is contract SPE2DB25FYQRV worth?
The government has obligated $14,744 on SPE2DB25FYQRV.
Is contract SPE2DB25FYQRV an order under another contract?
Yes. SPE2DB25FYQRV is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYQRV competed?
The extent of competition for SPE2DB25FYQRV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award